Heritage Wealth Management (Arizona)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$19K	Buy	300 +150	+100%	+$9.52K	﹤0.01%	672
2022 Q3	$9K	Hold	150	–	–	﹤0.01%	671
2022 Q2	$8.66K	Hold	150	–	–	﹤0.01%	685
2022 Q1	$9K	Buy	+150	New	+$9.15K	﹤0.01%	728
2021 Q3	$11K	Hold	150	–	–	﹤0.01%	643
2021 Q2	$12K	Hold	150	–	–	﹤0.01%	639
2021 Q1	$11K	Buy	+150	New	+$11.3K	0.01%	565

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s PBE Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Invesco Biotechnology & Genome ETF (PBE) stake by 100% in Q4 2022, buying an estimated $9.52K and bringing the position to 300 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Heritage Wealth Management (Arizona) first reported a position in PBE in Q1 2021 and has held it in 7 quarters since. 103 funds tracked by Wall St. Rank hold PBE as of Q4 2022.

Heritage Wealth Management (Arizona) held 300 shares of Invesco Biotechnology & Genome ETF worth $19K as of Q4 2022.
Heritage Wealth Management (Arizona) bought 150 Invesco Biotechnology & Genome ETF shares in Q4 2022, an estimated $9.52K.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #672 holding.
Heritage Wealth Management (Arizona) first reported a position in Invesco Biotechnology & Genome ETF in Q1 2021 and has held it in 7 quarters since.
103 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.